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ABSTRACT

Administration of Hyperoxia (>90 % oxygen) is a pervasive intervention to supplement
respiratory needs in patients admitted in ICU/critical care units. Current literature suggests that
prolonged use of Hyperoxia therapy is directly associated with in-hospital mortality. The exact
reason for this high mortality under Hyperoxia is unknown. Recent explorations in Dr. Panguluri
lab identified that dysregulation of Kv channels plays a vital role in the pathophysiology of
Hyperoxia-induced pulmonary and cardiac complications using animal models. The proposed
research will focus on the part of Hyperoxia in generating cardiotoxicity and ventricular
remodeling in the type-1 diabetes patients using the Akita, mouse model.

iv

BACKGROUND

Diabetes is a significant health hazard in all age groups, with a prevalence of >9.4% in
the adult population worldwide (WHO). It is one of the top five leading causes of death in the
global population, and One out of every four old patients are diagnosed with diabetes in united
states (Roglic et al., 2005). The global community under the risk of diabetes is increasing
gradually and can be a significant death inducer in the coming decades (Henning, 2018).
Diabetes is a complex disorder that causes high blood sugar due to insulin resistance or
insufficient insulin production by the pancreas, the molecular changes in glucose metabolism
were associated with many environmental and genetic factors influencing the insulin resistance
(Aziz, Farid, Qin, Wang, & Liu, 2018).
Insulin plays a significant role in carbohydrate metabolism and the regulation of blood
glucose levels according to the energy demands of the human body (Bacha & Klinepeter Bartz,
2016). About 90 to 95 % of the patients diagnosed with diabetes are old and are having type-2
diabetes where there is enough insulin production, but cells cannot access glucose due to lack of
response to insulin. The remaining 10 to 5% of the patients have type-1 in which the body does
not have enough insulin production and is most common in young population compared to older
people (CDC). It is sometimes hard to differentiate latent type-1 adult diabetes (juvenile T1DM
with a slow course of onset) from type-2 diabetes in the adult population because of similar
clinical manifestations (Borg et al., 2003). Type 1 Diabetes mellitus (T1D) is has a higher
incidence in males between 1539 ages compared to females (Diaz-Valencia, Bougnères, &
Valleron, 2015) (Tuomi et al., 1993). Any type of diabetes, irrespective of the dependence on
1

insulin, is a risk factor that exacerbates the symptoms associated with heart and lung failure
(Maack et al., 2018) (Boyle et al., 2018) (Tuomi et al., 1993).
The incidence of diabetic patients who develop the cardiovascular disease is very high,
and more than 70% of deaths in diabetes patients are due to heart failure associated with
myocardial fibrosis, systolic dysfunction, left ventricular dysfunction and hypertrophy (Khavandi
et al., 2009). Even though not all diagnosed diabetes patients have respiratory failure,
administration of mechanical ventilation or oxygen supplement is common practice to chronic
diabetic patients admitted into ICU. Mechanical ventilation was administered in various
circumstances ranging from coronary bypass surgeries to organ failures like obstructive
pulmonary disease (COPD) and respiratory failure (Pham, Brochard, & Slutsky, 2017). The
benefits of hyperoxia therapy (>90 % oxygen supply) were not entirely agreed upon, but it is still
a frequent intervention made to save patients' lives during cardiac or respiratory failure, septic
shock, brain trauma and in many surgical procedures (Brugniaux et al., 2018). Thus, there is a
need to consider hyperoxia therapy or pure oxygen supplementation as a less beneficial
intervention that needs to be minimally used under strict monitoring of blood oxygen reserves, to
avoid many in- hospital mortalities (Page et al., 2018).
Acute Lung Injury (ALI) in Hyperoxia
Hyperventilation or hyperoxia therapy became a primary cause of deaths related to
respiratory failure (Bellani et al., 2016). The amount of oxygen supplement given to the patient
can be periodically monitored as per the patient blood oxygen demands, any negligence or
increase in tidal volumes or pressure will lead to lung injury. (Bein et al., 2016). The partial
airway pressure during oxygen therapy should not exceed 300 mm/hg in an attempt to supply
adequate oxygen to the patient and is managed to prevent the ALI (Li et al., 2011) (Kim et al.,
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2014).
Many recent studies showed hyperoxia as a cause of death due to respiratory failure in
the Intensive Care Units (ICU) patients, this is because of the edema and inflammation of the
alveoli as a result of oxidative stress in the tissue fluids (Han et al., 2018; Pannu, 2016; Sato et
al., 2016). During hyperoxia exposure, reactive oxygen free radicals act as cytotoxins leading to
respiratory stress. This oxidative stress is due to the imbalance of free-radicals and anti-oxidants
in the cells, which leads to the production of the inflammatory mediators like RAS, TNF- alpha
that show deleterious effects on the heart tissue like hypertrophy, fibrosis and cardiac remodeling
(Reddy, Hassoun, & Brower, 2007).
Hyperoxia therapy in ICU patients was considered as a significant risk factor in
developing the acute lung injury causing the in-hospital mortality (Damiani, Donati, & Girardis,
2018). The studies also show there is excessive use of hyperventilation in urban geriatric
specialty care units in the United States and the level of risk may vary based on the amount of
pure oxygen used in the disease condition. Among the number of patients died due to
hyperventilation 13.2 % were diagnosed diabetic patients, and it is about 40-50% in certain
comorbid conditions like myocardial infarction and cardiomyopathy (Wunsch et al., 2010). Even
though hyperoxia is considered to show many vascular and non- toxic vascular effects, there are
very few control studies that demonstrate the risk involved with it in prolonged use (Abuzaid et
al., 2018; Cabello, Burls, Emparanza, Bayliss, & Quinn, 2016; Wijesinghe et al., 2009).
Cardiac Complications in Hyperoxia
Recent studies suggested the possibility of weight loss, increased heart weight, Cardiac
remodeling, and electrophysiological changed in the heart with Hyperoxia therapy using a
murine model. (K. C. Chapalamadugu, S. K. Panguluri, E. S. Bennett, N. Kolliputi, & S. M.
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Tipparaju, 2015). Dr. Panguluri laboratory is the first to study and report the cardiac effects of
hyperoxia in the adult mouse model. In their fundamental study, they demonstrated that
hyperoxia causes electrical remodeling and left ventricular hypertrophy using a wild-type mouse
model (S. K. Panguluri, J. Tur, J. Fukumoto, et al., 2013).
Hyperoxia is demonstrated as the major predisposing factor in inducing diabetic cardiomyopathy by disturbing the redox equilibrium between ROS and antioxidants in the blood (de
Cavanagh et al., 2001). The increased levels of redox stress will predispose many diabetic
complications associated with Cardiac failure (Maritim, Sanders, & Watkins, 2003). The
remodeling of heart in diabetic patients is to adjust the metabolism to changing conditions which
ultimately leads to sudden cardiac arrest, and This is due to the excessive levels of saturation
(>90%) of oxyhemoglobin in the cardiac cells (Llitjos, Mira, Duranteau, & Cariou, 2016).
Not only cardiac remodeling but also potassium channels present on the heart play a
significant role in developing cardiac myopathy in diabetic patients. The purpose of these
channels is to generate action potential essential for cardiac function (Casis, Gallego, Iriarte, &
SanchezChapula, 2000). Down-regulation of these channels indicate the changes in the
electrophysiology of the heart that may lead to cardiomyopathy (Nishiyama et al., 2001) (Qin et
al., 2001). Hyperoxia studies on mouse model demonstrated the dysregulation of potassium
channels like Kv4.2 that regulate the heartbeat; this leads to delayed action potential generating
prolonged QT intervals in the echocardiogram (S. K. Panguluri, J. Tur, K. C. Chapalamadugu, et
al., 2013).
Later using a DB/DB (8 to 10 weeks) animal model of type-2 diabetes Dr. Panguluri lab
published how Hyperoxia can cause arrhythmias and dysregulation of specific genes of oxygen
sensitive ion channels in people with diabetes. Along with this, they also observed an increase in
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the serum levels of cardiac markers like lactate dehydrogenase and cardiac troponin-1 (cTn1).
Existing cardiac dysfunction in diabetes patients can be worse with Hyperoxia exposure
indicating the harmful effects of mechanical ventilation in diabetic patients admitted to ICU
(Rodgers, Samal, Mohapatra, & Panguluri, 2018).
Hyperoxia can be an aggravating factor in T1DM patients. Recent studies demonstrated
low levels of insulin production and oxygen utilization in the pancreas in patients treated with
short-term of hyperventilation therapy (Hals et al., 2017). This reduced oxygen consumption at
the mitochondrial level will significantly increase the demand for insulin production with
adverse effects on vital organs like lungs and heart. Now in this study, an attempt was made to
demonstrate the potential pulmonary and cardiac effects of Hyperoxia in the type-1 diabetes ICU
setting using Akita mice (Type-1 diabetes model).
Animal Model Used in Hyperoxia Studies
Many medical research experiments use animals to represent the human biological
system to study various hypotheses. Later the experimental results in the animal models are
correlated with the actual human biological parameters to prove the proposed hypothesis. They
act as a window to observe various natural phenomena that occur in the disease conditions in
humans (Pasquali, 2018). These animals are designed according to the needs of the experiment
by morphological alterations and genetic mutations (Matute-Bello, Frevert, & Martin, 2008).
Rodents such as mice are widely used to test the biological effects of various potential
confounders in the use of drugs and disease (Iuamoto et al., 2017). Human genome studies show
that more than 90 % of the genes are similar in both mice and humans (Xuan, Wang, & Zhang,
2003; Yue et al., 2014). It is unethical to use human subjects to study chronic ailments, so they
use mouse models to simulate human clinical conditions. Many murine models are instrumented
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to reveal initial findings of pathophysiology and toxicology of various pulmonary disorders like
fibrosis and acute lung injury in different in-vitro settings (Miller & Spence, 2017).
The human simulation widely used to study the complications of insulin-dependent
diabetes in various in-vitro conditions is the Akita mouse model (Zhou et al., 2018). This strain
is developed accidentally by breeding diabetic male and typical female C57BL mice for about
seven generations (Thomas, Dalton, Malzer, & Marciniak, 2011). Nutrition boosted with high-fat
contents is fed to these mice will lead to the expression of diabetic symptoms in these mice
(Bhagat et al., 2018). Hyperglycemia in these high-fat diets fed Akita mice is passed to their
progeny characterized by low body weight, weal skeletal system, and compromised insulin
production (Grasemann et al., 2012).
This single gene expressing a genetically altered murine model is advantageous in
observing various biological phenotypes of type one diabetes condition like hyperglycemia and
hypoinsulinemia (Mathews, Langley, & Leiter, 2002). Many studies suggested that the Akita
strain is very useful in developing diabetic-nephropathy related complications (Brosius et al.,
2009). The onset of diabetes is very spontaneous in these mice due to natural risk factors like
abnormal renal metabolism associated with kidney failure (Zent et al., 2006).
The specific mutation of insulin-2 gene creates unusual conformation in protein structure
leading to pancreatic toxicity, these mice have very few beta cells in their pancreas and produce
less insulin developing insulin-dependent diabetes (Sentinelli et al., 2016). Majority of diabetic
symptoms noticed in the young mice of 21-28 days of age will correspond to young human age
(Gvazava, Rogovaya, Borisov, Vorotelyak, & Vasiliev, 2018). Different type 1 diabetic
complications (T1DM) complications like polydipsia, polyphagia, and polyuria are more clearly
seen in male mice predominantly (Kesherwani, Shahshahan, & Mishra, 2017). Cardiac
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Complications in Hyperoxia: Recent studies suggested the possibility of weight loss, increased
heart weight, Cardiac remodeling, and electrophysiological changed in the heart with Hyperoxia
therapy using a murine model. (K. C. Chapalamadugu, S. K. Panguluri, E. S. Bennett, N.
Kolliputi, & S. M. Tipparaju, 2015). Dr. Panguluri laboratory is the first to study and report the
cardiac effects of hyperoxia in the adult mouse model. In their fundamental study, they
demonstrated that hyperoxia causes electrical remodeling and left ventricular hypertrophy using
a wild-type mouse model (S. K. Panguluri, J. Tur, J. Fukumoto, et al., 2013).
Hyperoxia is demonstrated as the major predisposing factor in inducing diabetic cardiomyopathy by disturbing the redox equilibrium between ROS and antioxidants in the blood (de
Cavanagh et al., 2001). The increased levels of redox stress will predispose many diabetic
complications associated with Cardiac failure (Maritim, Sanders, & Watkins, 2003). The
remodeling of heart in diabetic patients is to adjust the metabolism to changing conditions which
ultimately leads to sudden cardiac arrest, and This is due to the excessive levels of saturation
(>90%) of oxyhemoglobin in the cardiac cells (Llitjos, Mira, Duranteau, & Cariou, 2016).
Not only cardiac remodeling but also potassium channels present on the heart play a
significant role in developing cardiac myopathy in diabetic patients. The purpose of these
channels is to generate action potential essential for cardiac function (Casis, Gallego, Iriarte, &
SanchezChapula, 2000). Down-regulation of these channels indicate the changes in the
electrophysiology of the heart that may lead to cardiomyopathy (Nishiyama et al., 2001) (Qin et
al., 2001). Hyperoxia studies on mouse model demonstrated the dysregulation of potassium
channels like Kv4.2 that regulate the heartbeat; this leads to delayed action potential generating
prolonged QT intervals in the echocardiogram (S. K. Panguluri, J. Tur, K. C. Chapalamadugu, et
al., 2013).
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Later using a DB/DB (8 to 10 weeks) animal model of type-2 diabetes Dr. Panguluri lab
published how Hyperoxia can cause arrhythmias and dysregulation of specific genes of oxygen
sensitive ion channels in people with diabetes. Along with this, they also observed an increase in
the serum levels of cardiac markers like lactate dehydrogenase and cardiac troponin-1 (cTn1).
Existing cardiac dysfunction in diabetes patients can be worse with Hyperoxia exposure
indicating the harmful effects of mechanical ventilation in diabetic patients admitted to ICU
(Rodgers, Samal, Mohapatra, & Panguluri, 2018).
Hyperoxia can be an aggravating factor in T1DM patients. Recent studies demonstrated
low levels of insulin production and oxygen utilization in the pancreas in patients treated with
short-term of hyperventilation therapy (Hals et al., 2017). This reduced oxygen consumption at
the mitochondrial level will significantly increase the demand for insulin production with
adverse effects on vital organs like lungs and heart. Now in this study, an attempt was made to
demonstrate the potential pulmonary and cardiac effects of Hyperoxia in the type-1 diabetes ICU
setting using Akita mice (Type-1 diabetes model). Animal Model used in Hyperoxia Studies:
Many medical research experiments use animals to represent the human biological system to
study various hypotheses. Later the experimental results in the animal models are correlated with
the actual human biological parameters to prove the proposed hypothesis. They act as a window
to observe various natural phenomena that occur in the disease conditions in humans (Pasquali,
2018). These animals are designed according to the needs of the experiment by morphological
alterations and genetic mutations (Matute-Bello, Frevert, & Martin, 2008).
Rodents such as mice are widely used to test the biological effects of various potential
confounders in the use of drugs and disease (Iuamoto et al., 2017). Human genome studies show
that more than 90 % of the genes are similar in both mice and humans (Xuan, Wang, & Zhang,
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2003; Yue et al., 2014). It is unethical to use human subjects to study chronic ailments, so they
use mouse models to simulate human clinical conditions. Many murine models are instrumented
to reveal initial findings of pathophysiology and toxicology of various pulmonary disorders like
fibrosis and acute lung injury in different in-vitro settings (Miller & Spence, 2017).
The human simulation widely used to study the complications of insulin-dependent
diabetes in various in-vitro conditions is the Akita mouse model (Zhou et al., 2018). This strain
is developed accidentally by breeding diabetic male and typical female C57BL mice for about
seven generations (Thomas, Dalton, Malzer, & Marciniak, 2011). Nutrition boosted with high-fat
contents is fed to these mice will lead to the expression of diabetic symptoms in these mice
(Bhagat et al., 2018). Hyperglycemia in these high-fat diets fed Akita mice is passed to their
progeny characterized by low body weight, weal skeletal system, and compromised insulin
production (Grasemann et al., 2012). This single gene expressing a genetically altered murine
model is advantageous in observing various biological phenotypes of type one diabetes condition
like hyperglycemia and hypoinsulinemia (Mathews, Langley, & Leiter, 2002). Many studies
suggested that the Akita strain is very useful in developing diabetic-nephropathy related
complications (Brosius et al., 2009). The onset of diabetes is very spontaneous in these mice due
to natural risk factors like abnormal renal metabolism associated with kidney failure (Zent et al.,
2006).
Functional Parameters in Hyperoxia
Many fundamental physiological factors vary during Hyperoxia therapy in diabetic mice.
Studies suggest there is a significant loss of body weight and reduction in heart weight during
Hyperoxia exposure (Figure 1, Page 11).
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The echocardiogram studies indicate prolonged RR intervals and lowered QRS interval or
higher QT and JT curve intervals depicting the presence of bradycardia or slow heart rate in
Hyperoxia condition. Bradycardia in the Hyperoxia mice indicates the risk of congestive heart
failure shortly (Crow, Hannan, & Folsom, 2003) (Yan & Antzelevitch, 1998). Bioassay of serum
samples diabetic mice indicates the increase in the levels of biochemical markers like cardiac
troponin-1 (regulate the contraction of cardiac muscle) and Lactate dehydrogenase confirming the
presence of vascular injury (K. C. Chapalamadugu et al., 2015).

Figure 1. Reduced Body and heart weight after Hyperoxia (Rodgers et al., 2018).
Quantitative-PCR studies done to identify the dysregulation of the expression of genes
coding for potassium channels in the heart muscle cells (especially Kv 4.2, 1.5 and KchPi2)
reducing their function at the molecular level (Rodgers et al., 2018). The distinct downregulation
of potassium channel expression is a clear indication of the arrhythmia development in ventricles
(Yan & Antzelevitch, 1998).
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Figure 2. Electrocardiography parameters in Hyperoxia treated diabetic mice (Rodgers et al.,
2018).

Figure 3. Deregulated potassium channel gene expression in Hyperoxia (Rodgers et al.,
2018).
Hemodynamic parameters like blood pressure, heart rate, pulmonary oxygen
saturation, and arterial blood flow get altered in the Hyperoxia condition (Gordin et al., 2012;
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Ronnback et al., 2004). Studies suggest that there are elevated blood pressure and restricted
arterial blood flow due to rigid arterial vasculature indicating the development of cardiac
ailments like diabetic nephropathy and retinopathy (Prince et al., 2010).
Table 1. Clinical Parameters Associated with Hyperoxia in Type I Diabetes (Gordin et al., 2016).
Clinical parameter
No of subjects
Gender (male/female)
Age group (years)
Duration of T1DM (years)
Age of onset (years)
BMI (kg/m2)

Waist/Hip ratio
Blood glucose (mmol/l)
Hb (g/l)
HbA1c (%)
HbA1c (mmol/mol)
Total cholesterol (mmol/l)
HDL-cholesterol (mmol/l)
Triacylglycerol (mmol/l)
Urinary AER (mg/24 h)
Serum creatinine (μmol/l)
Insulin per body weight (IU/kg)

Type 1 diabetes

Controls

98

49

56/42
31.9 ± 6.5
13.5 ± 4.9
17.9 ± 5.2
25.4 ±
4.9
0.87 ± 0.07
8.4 (4.5–13.0)
147 ± 12
8.06 ± 1.15
65 ± 7
4.54 ± 0.81
1.62 ± 0.0.50
1.02 (0.76–1.30)
5 (2–8)
69 ± 12
0.77 ± 0.3

P-value

22/27
32.7 ± 8.9
–
–
23.7 ± 3.9

NS
NS

0.86 ± 0.08
4.6 (3.9–5.0)
–
5.24 ± 0.21
31 ± 1
4.34 ± 0.75
1.64 ± 0.50
0.78 (0.57–1.01)
6 (4–7)
72 ± 13
–

NS
<0.001

NS

<0.001
<0.001
NS
NS
<0.05
NS
NS

Study results indicate variations in systolic and diastolic blood pressures along with many
other hemodynamic parameters like reduced oxygen saturation in T1DM-hyperoxia subjects as
shown in Table 1 (Gordin et al., 2016). There is an age-old evidence stating that diabetes
precipitates oxidative-stress, Cardiac hypertrophy, infraction, fibrosis, dysfunction of ventricles
and arrhythmias. Diabetic mice did not demonstrate any Hyperoxia related cardiac hypertrophy.
whereas wild-type mice showed an increase in the heart weights significantly. Diabetic mice also
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displayed Brady arrhythmias and potassium channel dysregulation considering Hyperoxia as an
exacerbating risk factor for cardiac myopathy and dysfunction (Rodgers et al., 2018).
Some study results showed heterozygous control mice have more heart weight
compared to diabetic group whereas some studies reported no significant difference between
the two groups (Soltysinska, Speerschneider, Winther, & Thomsen, 2014) (Venardos, De
Jong, Elkamie, Connor, & McGee, 2015). The geriatric mice (30 weeks) showed both
increased heart weight (hypertrophy) and thickened wall in left ventricles under similar
experimental conditions (Hall, Maready, Hall, & Stec, 2014). Dysregulation of the potassium
channels in the heart is directly associated with the ventricular hypertrophy (Suzuki et al.,
2012).
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RATIONALE & HYPOTHESIS

Rationale
This study will help to find the cardiac abnormalities in T1D Akita mouse models under
Hyperoxia (72 hrs.) or simulated ICU conditions. This study will determine and compare the
expression of Potassium Ion channels and Serum cardiac markers in Normoxia and Hyperoxia
treated male Akita mice. In this study Surface Echocardiography and Electrocardiogram analysis
will help in distinct identification of negative impact of Hyperoxia therapy in T1D patients.
Hypothesis
Diabetes is a leading cause of mortality in all age groups with a prevalence of >9.4% in
the adult population and is the fifth leading cause of death in the global population and One out
of every four old patients are diagnosed with diabetes in united states (WHO). Since Type 1
Diabetes mellitus (T1D) is having a higher incidence in males between 15-39 ages compared to
females this study is conducted in male Akita type 1 diabetic mouse model. The incidence of
diabetic patients getting a cardiovascular disease is very high and studies done in Dr. Panguluri’s
lab demonstrated for the first time that pure oxygen supplementation during the ICU admission is
worsening the cardiac pathophysiology. This argumentative ICU intervention in some
circumstances leads to patient mortality due to respiratory failure or ALI.
In their fundamental study Dr.Panguluri’s research team showed how Hyperoxia causes
electrical remodeling and left ventricular hypertrophy followed by reporting the dysregulation of
potassium channels like Kv4.2 that regulate the heartbeat; which lead to delayed action potential

14

generating prolonged QT intervals in the echocardiogram . Along with this, they also observed
existing cardiac dysfunction and the increase in the serum levels of cardiac markers like lactate
dehydrogenase and cardiac troponin-1 in diabetic mouse models.
Hyperoxia can be an aggravating factor in the T1DM patients. Recent studies
demonstrated low levels of insulin production and oxygen utilization in the pancreas in patients
treated with short term of hyperventilation therapy can reduce oxygen consumption at the
mitochondrial level thereby significantly increasing the demand for insulin production with
adverse effects on vital organs like lungs and heart. Now in this study, we are trying to
demonstrate the potential pulmonary and cardiac effects of Hyperoxia in the type-1 diabetes ICU
setting using Akita mice (Type-1 diabetes model).
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MATERIALS & METHODS
Animal Model
Animal models act as a window to observe various natural phenomena that occur in the
disease conditions in humans (Pasquali, 2018). These animals are designed according to the
needs of the experiment by morphological alterations and genetic mutations (Matute-Bello et al.,
2008). Rodents such as mice are widely used to test the biological effects of various potential
confounders in the use of drugs and disease (Iuamoto et al., 2017). Human genome studies show
that there is more than 90 % similarity of the genes in both mice and humans (Xuan et al., 2003;
Yue et al., 2014). The human simulation widely used to study the complications of insulindependent diabetes in various in-vitro conditions is the Akita mouse model (Zhou et al., 2018).
This strain is developed accidentally by breeding diabetic male and typical female C57BL mice
for about seven generations (Thomas et al., 2011). Nutrition boosted with high-fat contents is fed
to these mice will lead to the expression of diabetic symptoms in these mice (Bhagat et al.,
2018). Hyperglycemia in these highfat diets fed Akita mice is passed to their progeny
characterized by low body weight, weak skeletal system, and compromised insulin production
(Grasemann et al., 2012). This single gene expressing genetically altered murine model is
advantageous in observing various biological phenotypes of type one diabetes condition like
hyperglycemia and hypoinsulinemia (Mathews et al., 2002). Many studies suggested that the
Akita strain is very useful in developing diabetic nephropathy related complications (Brosius et
al., 2009). The onset of diabetes is very spontaneous due to natural risk factors like abnormal
renal metabolism associated with kidney failure (Zent et al., 2006).
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Exposure to Hyperoxia
Adult male mice (Akita strain) 8– 9 wks. Of age got from Jackson Laboratories were
randomly allocated and exposed to room air or Hyperoxia and were utilized as Normoxia or
Hyperoxia groups, separately in an airtight or sealed chamber (50 × 50 × 30 cm). For Hyperoxia
treatment, mice were presented to Hyperoxia (100% O2) for 72 h and euthanized directly after
the exposure time frame is finished (Siva K Panguluri et al., 2013). An oxygen analyzer
(Vascular Technology, Chelmsford, MA) was utilized to screen oxygen levels all through the
Hyperoxia exposure. After exposure, mice were anesthetized for surface ECG with isoflurane
and afterward euthanized for thoracotomy by means of intraperitoneal infusion (IP) of 50 mg/kg
Euthasol, which was pursued quickly by blood accumulation and heart extraction. Blood was
centrifuged at 5500 rpm for 5 min to gather plasma serum. Every heart was dissected to isolate
right and left ventricles, pinnacle, chamber, and septum. Heart segments were put away at − 80
°C for resulting investigation, including RNA and protein-analysis. (Rodgers et al., 2018).
Electrocardiogram recording (ECG)
ECG recordings were acquired on mice anesthetized with isoflurane (1– 2%) utilizing
surface probes in lead II design. ECG's were recorded for a total length of 15 minutes, with 1minute frames recorded at 5-minute intervals to estimate the heart rate. The signal is obtained at
1000 µs rate by utilizing Power Lab framework worked with Lab Chart 7.2 programming (AD
Instruments, UK), and offline analysis can be done using the ECG module of Lab Chart 7.2
programming (Kalyan C Chapalamadugu, Siva K Panguluri, Eric S Bennett, Narasaiah Kolliputi,
& Srinivas M Tipparaju, 2015). RR, PR, QRS, and JT Intervals (millseconds) were estimated.
QT is calculated from the beginning of Q peak to the point where the T wave comes back to the
isoelectric baseline (TP ), and pulse revised QT (QTc) interval was estimated by the Bazett's
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equation (QTc=QT/RR1/2) (Berul, Aronovitz, Wang, & Mendelsohn, 1996).
Echocardiogram (Echo)
Echo is a commonly used Non-invasive technique to identify the prominent cardiac
structural changes responsible for the cardiac dysfunction. The 2DimensionalEchocardiography
(2D-Echo) is a commonly utilized technique with the mouse models to identify the changes in
the Left ventricular functioning during the cardiac systole and Diastole (Gao, Ho, Vatner, &
Vatner, 2011). Echo is performed after the Hyperoxia treatment in both experimental and control
groups to identify the structural changes like Hypertrophy and Cardiomyopathy (S. K. Panguluri,
J. Tur, K.C. Chapalamadugu, et al., 2013).
The specific mutation of insulin-2 gene create unusual conformation in protein structure
leading to pancreatic toxicity, these mice have very few beta cells in their pancreas and produce
less insulin developing insulin-dependent diabetes (Sentinelli et al., 2016). Majority of diabetic
symptoms noticed in the young mice of 21-28 days of age will correspond to young human age
(Gvazava et al., 2018). Various T1DM complications like polydipsia, polyphagia, and polyuria
are more clearly seen in male mice predominantly (Kesherwani et al., 2017).
All mice were enabled access to both food and water ad libitum for the duration of this
experiment and were kept up on a 12 h light/dark cycle. Each experimental research protocol was
affirmed by the Institutional Animal Care and Use Committee at the University of South Florida
(Tampa, FL), under the supervision of US National Institutes of Health (Rodgers et al., 2018).
Statistical-Analysis
Data were analyzed using Student’s t-test to compare quantitative data populations with
normal distributions and equal variance and by two-way analysis of variance (ANOVA).
Analysis compares data between Control group to treatment groups, and results were expressed
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as means of ± standard deviation (SE). A P-value greater than 0.05 was considered statistically
significant except if generally indicated (Rodgers et al., 2018).
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RESULTS
The sample size of both experimental and Control groups is determined by using a
sample size calculator. The male Akita mice of 8 to 10 weeks of age were purchased from
Jackson’s laboratory are distributed equally (6 mice in each group) among Hyperoxia and
Normoxia groups. The Hyperoxia chamber supplied with continuous supply of pure oxygen is
used to treat the experimental group for 72 hrs. The control group is left in cages at normal
atmospheric room condition for the same period.
Physical parameters: Total no of male Akita mice exposed to Hyperoxia or 72 hr.-Pure
oxygen therapy are six and the control group consists of six heterozygous control mice exposed
to normal oxygen supply. Any sudden deaths or animal withdrawal from the group didn’t occur
throughout the Hyperoxia experiment. Regular inspection of the experimental groups is done for
every four hours to determine the progress of the Hyperoxia treatment by monitoring the oxygen
supply levels and its flow rate to the Hyperoxia chamber. Continuous supply of food and water is
supplied along with 12-hour light and dark cycles to simulate day and night. All the physical
parameters like body weight, blood glucose, blood pressure and heart rates are compared during
or after the Hyperoxia therapy. Whereas in Normoxia group there is a significant increase in the
body weight.
The Hyperoxia group in contrast demonstrated severe weight irrespective of the irrational
supply of food and water to both the Hyperoxia and Normoxia group. The body weights of the
experimental animals are measured both before and after the Hyperoxia therapy and normalized
with the tibia length for comparision. Initial body weight in both the experimental groups is
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determined before starting the Hyperoxia treatment and the final body weight is determined
either before sacrificing the animal for organ harvesting and blood collection or before recording
the Electrocardiogram (ECG).
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Figure 4. Comparison of Body weight normalized to Tibia Length
Physical Parameters
The Normoxia group exhibited a significant weight gain whereas the Hyperoxia group
exhibited a very severe weight loss. Other physical parameters like blood pressure, heart rate
and saturated oxygen levels were determined using the glucometer. Similarly, recorded heart
rates in the Normoxia group exhibited arrhythmias which are very close to tachycardia
(elevated heart rates) levels but are not significant. Since Akita mice are initially diabetic
blood glucose levels are determined to be significantly higher both before and after the
treatment indicating the Hyperglycemia.
Interestingly Hyperoxia group demonstrated a very significant weight loss which is
about 30 percent of its initial body weight before starting the Hyperoxia therapy. Which
indicate the effect of Hyperoxia in compromising the regular glucose metabolism and muscle
21

wasting in the experimental group. The recorded heart rates are significantly low in the
Hyperoxia mice which indicated the Arrhythmias, in comparison with the Normoxia group
these are found to be bradycardia (slow heart rate). The blood glucose levels indicated signs
of hypoglycemia in the Hyperoxia group.

Table 2. Comparison of Body Weights in Hyperoxia Treatment.

Treatment
Normoxia
for 72 hrs.

Hyperoxia
For 72 hrs.

ID
1
2
3
4
5
6

Initial BW
16.8 gm
18.2 gm
16.2 gm
18.5 gm
16.8 gm
18.1 gm

BW After
21.8 gm
20.5 gm
20.4 gm
19.9 gm
17.7 gm
18.7 gm

Difference
↑ 5.0 gm
↑ 2.3 gm
↑ 4.2 gm
↑ 1.4 gm
↑ 0.9 gm
↑ 0.6 gm

Tibia length
19 cm
19 cm
19 cm
19 cm
19 cm
19 cm

7
8
9
10
11
12

19.7 gm
22.5 gm
21.9 gm
22.7 gm
21.5 gm
22.6 gm

16.1 gm
18.5 gm
18.0 gm
18.7 gm
17.8 gm
18.7 gm

↓ 3.6 gm
↓ 4.0 gm
↓ 3.9 gm
↓ 4.0 gm
↓ 3.7 gm
↓3.9 gm

19 cm
19 cm
19 cm
19 cm
19 cm
19 cm

Table 3. Comparison of Physical Parameters in Hyperoxia Treatment.

Treatment

Normoxia
For 72 hrs.

Hyperoxia
For 72 hrs.

1
2

ID

Glucose
HI (>500)
HI (>500)

SP02
96%
65%

Heart Rate
409.800 bpm
423.500 bpm

Tibia length
19 cm
19 cm

3
4
5
6
7
8
9
10
11
12

HI (>500)
356 mm/Hg
HI (>500)
332 mm/Hg
325 mm/Hg
319 mm/Hg
336 mm/Hg
HI (>500)
374 mm/Hg
375 mm/Hg

96%
92%
94%
95%
98%
97%
98%
94%
94%
97%

431.167 bpm
468.433 bpm
442.467 bpm
457.033 bpm
189.667 bpm
158.025 bpm
199.367 bpm
226.967 bpm
207.033 bpm
182.667 bpm

19 cm
19 cm
19 cm
19 cm
19 cm
19 cm
19 cm
19 cm
19 cm
19 cm
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Cardiac Functional Parameters
The electrical properties of the heart can be determined by electrophysiology technique
called electrocardiography (ECG or EKG). Since the physical parameters suggested arrhythmias
in both the Normoxia and the Hyperoxia groups so there is a need to confirm these functional
abnormalities by recording the electrocardiogram by using the Lab Chart 8 (ECG analysis
software). Changes in the magnitude of the cardiac action potentials are determined by placing
the 3 leads in the left upper limb and both the hind limbs.
Along with the well-defined changes in the physical parameters there are significant
changes in the cardiac functioning like prolonged arrhythmias in the Hyperoxia group and
absence of any sort of arrhythmia in the control population. Concluding that the 72hr Hyperoxia
treatment has generated clear risk of cardiac structural dysfunction in both the groups. The
electrocardiogram analysis of the Hyperoxia heart traces gave the impression of slow and
prolonged T-wave indicating the defect in the repolarization and arrhythmias are seen at least in
3 out of 6 Hyperoxia male Akita mice during the ECG analysis.

Figure 5. Electrocardiogram of typical Normoxia Akita Mice.
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Comparison of the Echocardiogram findings in both the Normoxia and the Hyperoxia
groups indicated the presence of arrhythmias. ST segment depression and Compressed RR
intervals, QRS complex, QT and JT segments confirmed the increased heart rate or mild
symptoms of tachycardia in the Normoxia group whereas ST elevation and elevated other
intervals (RR, QRS, QT and JT segments) confirmed the presence of bradycardia or reduced
heart rate in the Hyperoxia treated animal group.

Figure 6. Electrocardiogram of typical Hyperoxia Akita Mice.
Electrophysiological Parameters
Echocardiography (echo) is proved to be the best non-invasive technique to diagnose any
heart structural abnormalities that will impact the physiology of the heart like the heart structural
parameters like heart size and its wall thickness and blood pumping capacity. In these type I
diabetic experimental and control groups main focus is laid to determine the left ventricular heart
thickness during the systole and diastole along with the End diastolic volume, End Systolic
Volume, Stroke Volume, and Cardiac output (EDV, ESV, SV and CO).
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Table 4. Comparison of Physical Parameters Between Experimental Groups.
Treatment

Normoxia
For
72 hrs.

Hyperoxia
For
72 hrs.

ID

RR (ms)

QRS (ms)

QT (ms)

JT (ms)

ST (mV)

1
2

146.80
144.57

8.7648
11.81

22.4325
26.4433

13.67
14.63

0.1539
0.1549

3

139.27

8.554

21.7267

13.17

0.0498

4

128.43

12.423

25.5667

13.14

0.1461

5

137.00

11.543

25.8633

14.35

0.0768

6

134.10

9.8843

24.8167

15.10

0.1706

Mean

138.36

10.4965

24.4748

14.01

0.1253

SD

6.7709

1.654

1.941

0.808

0.049

7

327.33

11.96

64.6567

52.7

0.0052

8

379.95

14.445

54.0925

39.65

0.5924

9

312.13

12.703

63.9833

51.28

0.3493

10

293.57

15.037

42.4067

27.37

0.3193

11

299.50

87.307

79.3833

70.65

0.2218

12
Mean

330.07

11.877

51.9767

40.10

0.2965

323.76

25.554

59.4165

46.96

0.2974

SD

31.1291

30.280

12.8063

14.812

0.1904

Figure 7. Echocardiogram in Normoxia Akita Mice.
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Figure 8. Echocardiogram in Hyperoxia Akita Mice.
Careful analysis of the echocardiogram values between both the experimental groups
indicated the significant reduction in the left ventricular wall thickness in the Hyperoxia group
indicating the presence of cardiomyopathy in the form of reduced heart size may be due to
cardiac dystrophy. Whereas heart size of Normoxia mice is comparatively larger than the
Hyperoxia group indicating negative effect of Hyperoxia treatment in the type-1 diabetic disease
condition. The mean and average of each and every indicative parameter is calculated and listed
in Table 5, Page 33.
The blood volume in the ventricles before (ESV) and after (EDV) the cardiac cycle and
their difference (SV) in the Hyperoxia group indicated significant three fold reduction in the
cardiac output indicating how Hyperoxia is drastically compromising the oxygen supply to the
organs. Which clearly indicate the presence of cardiomyopathy and chances of heart failure in
the Akita mouse model with prolonged Hyperoxia treatment greater than 72 hrs. All the
Electrophysiological parameters indicating the effects of Hyperoxia are mentioned below.
The key parameters to determine the functioning of the heart based on the measurements
of the blood flow in the left ventricle are Ejection fraction (EF) and Fractional Shortening (FS).
Comparison of these values between the Normoxia and the Hyperoxia Groups indicate the left
ventricle in the Hyperoxia heart is trying to pump more blood than usual, trying to compensate
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the controversial development of oxygen demand in the Hyperoxia mice irrespective of the
continuous supply of 100% pure oxygen continuously for 72 hrs.

Table 5. Comparison of Experimental Parameters Between Experimental Groups.
Treatment

ID

LVID; s
Avg
2.638

EDV

ESV

SV

CO

1

LVID; d
Avg
4.07

67.419

18.353

0.049

20.411

Normoxia

2

4.02

2.997

64.964

26.910

0.038

15.830

For

3

3.5

2.461

42.875

14.907

0.027

11.634

4

3.8

2.619

54.872

17.961

0.036

15.354

5

4.07

3.239

67.419

33.977

0.033

13.911

6

3.88

2.723

58.411

20.197

0.038

15.896

Mean 3.89

2.779

59.326

22.051

0.037

15.506

SEM 0.09

0.116

3.890

2.890

0.002

1.1814

7

2.87

1.419

23.667

2.857

0.021

4.474

Hyperoxia

8

2.92

1.319

24.897

2.294

0.023

4.859

For

9

3.15

2.107

31.124

9.349

0.022

4.681

10

2.90

1.617

24.333

4.225

0.020

4.323

11

2.95

1.898

25.701

6.835

0.019

4.056

12

2.87

1.342

23.750

2.418

0.021

4.586

Mean 2.94

1.617

25.578

4.663

0.021

4.497

SEM 0.04

0.132

1.152

1.166

0.001

0.115

72 hrs.

72 hrs.
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Figure 9. Graphs representing of Fractional shortening (%FS) and Ejection fraction (%EF).

28

DISCUSSION

Mechanical ventilation is a very common type of medical intervention during treatment
of patients with breathing difficulties in intensive care units (ICUs), where there is continuous
supply of pure oxygen for a significant period of time. In previous studies conducted in
Dr.Panguluri’s laboratory, they demonstrated significant weight loss in the physical parameters
like body weight during hyperoxia treatment, using wild type male mice (C57BL/6) young adult
mice of 8 to 10 weeks of age) , but there is much more significant weight loss in the present
Akita males (Rodgers, Rodgers, Tian, Allen-Gipson, & Panguluri, 2019).Similar study
conducted in the wild type mice also indicated the presence of arrhythmias in the male hyperoxia
group (Rodgers et al., 2019).
Comparatively in the present study conducted in the Akita mice demonstrated the
presence of arrhythmias in both the normoxia and hyperoxia experimental groups, which showed
tachycardia and bradycardia, respectively. Some previous studies conducted in wild type mice
also demonstrated the presence of cardiac injury and hypertrophy along with the prolongation of
the QT and JT intervals in the hyperoxia treated wild type male population (K. C.
Chapalamadugu et al., 2015).
Cardiac remodeling induced by hyperoxia and significant reduction in the heart rate
(bradycardia) and cardiac output (CO) in the young adult male wild type mice during the
hyperoxia therapy (S.K. Panguluri, J. Tur, J. Fukumoto, et al., 2013). In the present study, we
also observed significant reduction in heart rate (HR) and more significant fall in the CO is
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observed. Whereas in the type 2 diabetes male wild type population a clear decrease in HR and
QRS duration is observed indicating the presence of bradycardia similar to present type-1
diabetic experimental male Akita mouse model (Rodgers et al., 2018).
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CONCLUSION
Mechanical ventilation is a common medical intervention in critical care patients.
Observing the significant uptrend in the prevalence of cardiovascular risk in the diabetic patient
population, hyperoxia studies were conducted in type 2 diabetic mouse models in Dr. Panguluri’s
lab demonstrating for the first time how 100 % pure oxygen supplementation worsened cardiac
functioning by exhibiting arrhythmias (Rodgers et al., 2018). In the present experimental study
conducted in male Akita mice, we have also demonstrated arrhythmias, along with weight loss,
thereby indicating clear risk of hyperoxia therapy in diabetic type 1 patients. Further comparative
studies can be done using the Akita female mice to compare the risks associated with gender
with hyperoxia therapy.
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